Skip to main content
Top
Published in: BMC Infectious Diseases 1/2009

Open Access 01-12-2009 | Technical advance

Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional analysis

Authors: Janneke H van Dijk, Catherine G Sutcliffe, Bornface Munsanje, Francis Hamangaba, Philip E Thuma, William J Moss

Published in: BMC Infectious Diseases | Issue 1/2009

Login to get access

Abstract

Background

Successful antiretroviral treatment programs in rural sub-Saharan Africa may face different challenges than programs in urban areas. The objective of this study was to identify patient characteristics, barriers to care, and treatment responses of HIV-infected children seeking care in rural Zambia.

Methods

Cross-sectional analysis of HIV-infected children seeking care at Macha Hospital in rural southern Zambia. Information was collected from caretakers and medical records.

Results

192 HIV-infected children were enrolled from September 2007 through September 2008, 28% of whom were receiving antiretroviral therapy (ART) at enrollment. The median age was 3.3 years for children not receiving ART (IQR 1.8, 6.7) and 4.5 years for children receiving ART (IQR 2.7, 8.6). 91% travelled more than one hour to the clinic and 26% travelled more than 5 hours. Most participants (73%) reported difficulties accessing the clinic, including insufficient money (60%), lack of transportation (54%) and roads in poor condition (32%). The 54 children who were receiving ART at study enrollment had been on ART a median of 8.6 months (IQR: 2.7, 19.5). The median percentage of CD4+ T cells was 12.4 (IQR: 9.2, 18.6) at the start of ART, and increased to 28.6 (IQR: 23.5, 36.1) at the initial study visit. However, the proportion of children who were underweight decreased only slightly, from 70% at initiation of ART to 61% at the initial study visit.

Conclusion

HIV-infected children in rural southern Zambia have long travel times to access care and may have poorer weight gain on ART than children in urban areas. Despite these barriers, these children had a substantial rise in CD4+ T cell counts in the first year of ART although longer follow-up may indicate these gains are not sustained.
Appendix
Available only for authorised users
Literature
1.
go back to reference UNAIDS: 2008 Report on the global AIDS epidemic. 2008, Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS UNAIDS: 2008 Report on the global AIDS epidemic. 2008, Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS
3.
go back to reference WHO: Towards Universal Access: Scaling up priority HIV/AIDS interventions in the health sector: Progress Report 2008. 2008, Geneva, Switzerland: World Health Organization WHO: Towards Universal Access: Scaling up priority HIV/AIDS interventions in the health sector: Progress Report 2008. 2008, Geneva, Switzerland: World Health Organization
4.
go back to reference Harries AD, Nyangulu DS, Hargreaves NJ, Kaluwa O, Salaniponi FM: Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet. 2001, 358: 410-414. 10.1016/S0140-6736(01)05551-9.CrossRefPubMed Harries AD, Nyangulu DS, Hargreaves NJ, Kaluwa O, Salaniponi FM: Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet. 2001, 358: 410-414. 10.1016/S0140-6736(01)05551-9.CrossRefPubMed
6.
go back to reference Sutcliffe CG, van Dijk JH, Bolton C, Persaud D, Moss WJ: Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis. 2008, 8: 477-489. 10.1016/S1473-3099(08)70180-4.CrossRefPubMed Sutcliffe CG, van Dijk JH, Bolton C, Persaud D, Moss WJ: Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis. 2008, 8: 477-489. 10.1016/S1473-3099(08)70180-4.CrossRefPubMed
7.
go back to reference Scott VE, Chopra M, Conrad L, Ntuli A: How equitable is the scaling up of HIV service provision in South Africa?. S Afr Med J. 2005, 95: 109-113.PubMed Scott VE, Chopra M, Conrad L, Ntuli A: How equitable is the scaling up of HIV service provision in South Africa?. S Afr Med J. 2005, 95: 109-113.PubMed
8.
go back to reference Ojikutu B: Introduction: the realities of antiretroviral therapy rollout: overcoming challenges to successful programmatic implementation. J Infect Dis. 2007, 196 (Suppl 3): S445-448. 10.1086/521123.CrossRefPubMed Ojikutu B: Introduction: the realities of antiretroviral therapy rollout: overcoming challenges to successful programmatic implementation. J Infect Dis. 2007, 196 (Suppl 3): S445-448. 10.1086/521123.CrossRefPubMed
9.
go back to reference Egger M, Boulle A, Schechter M, Miotti P: Antiretroviral therapy in resource-poor settings: scaling up inequalities?. Int J Epidemiol. 2005, 34: 509-512. 10.1093/ije/dyi110.CrossRefPubMed Egger M, Boulle A, Schechter M, Miotti P: Antiretroviral therapy in resource-poor settings: scaling up inequalities?. Int J Epidemiol. 2005, 34: 509-512. 10.1093/ije/dyi110.CrossRefPubMed
10.
go back to reference WHO: Taking Stock: Health worker shortages and the response to AIDS. 2006, Geneva, Switzerland: World Health Organization WHO: Taking Stock: Health worker shortages and the response to AIDS. 2006, Geneva, Switzerland: World Health Organization
11.
go back to reference Landman KZ, Thielman NM, Mgonja A, Shao HJ, Itemba DK, Ndosi EM, Tribble AC, Shao JF, Bartlett JA, Crump JA: Antiretroviral treatment literacy among HIV voluntary counseling and testing clients in Moshi, Tanzania, 2003 to 2005. J Int Assoc Physicians AIDS Care (Chic Ill). 2007, 6: 24-26. 10.1177/1545109706298479.CrossRef Landman KZ, Thielman NM, Mgonja A, Shao HJ, Itemba DK, Ndosi EM, Tribble AC, Shao JF, Bartlett JA, Crump JA: Antiretroviral treatment literacy among HIV voluntary counseling and testing clients in Moshi, Tanzania, 2003 to 2005. J Int Assoc Physicians AIDS Care (Chic Ill). 2007, 6: 24-26. 10.1177/1545109706298479.CrossRef
12.
go back to reference Rosen S, Ketlhapile M, Sanne I, Desilva MB: Characteristics of Patients Accessing Care and Treatment for HIV/AIDS at Public and Nongovernmental Sites in South Africa. J Int Assoc Physicians AIDS Care (Chic Ill). 2008, 7: 200-207. 10.1177/1545109708320684.CrossRef Rosen S, Ketlhapile M, Sanne I, Desilva MB: Characteristics of Patients Accessing Care and Treatment for HIV/AIDS at Public and Nongovernmental Sites in South Africa. J Int Assoc Physicians AIDS Care (Chic Ill). 2008, 7: 200-207. 10.1177/1545109708320684.CrossRef
13.
go back to reference Mshana GH, Wamoyi J, Busza J, Zaba B, Changalucha J, Kaluvya S, Urassa M: Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program. AIDS Patient Care STDS. 2006, 20: 649-657. 10.1089/apc.2006.20.649.CrossRefPubMed Mshana GH, Wamoyi J, Busza J, Zaba B, Changalucha J, Kaluvya S, Urassa M: Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program. AIDS Patient Care STDS. 2006, 20: 649-657. 10.1089/apc.2006.20.649.CrossRefPubMed
14.
go back to reference Wools-Kaloustian K, Kimaiyo S: Extending HIV care in resource-limited settings. Curr HIV/AIDS Rep. 2006, 3: 182-186. 10.1007/s11904-006-0014-1.CrossRefPubMed Wools-Kaloustian K, Kimaiyo S: Extending HIV care in resource-limited settings. Curr HIV/AIDS Rep. 2006, 3: 182-186. 10.1007/s11904-006-0014-1.CrossRefPubMed
15.
go back to reference Fredlund VG, Nash J: How far should they walk? Increasing antiretroviral therapy access in a rural community in northern KwaZulu-Natal, South Africa. J Infect Dis. 2007, 196 (Suppl 3): S469-473. 10.1086/521115.CrossRefPubMed Fredlund VG, Nash J: How far should they walk? Increasing antiretroviral therapy access in a rural community in northern KwaZulu-Natal, South Africa. J Infect Dis. 2007, 196 (Suppl 3): S469-473. 10.1086/521115.CrossRefPubMed
16.
go back to reference Bedelu M, Ford N, Hilderbrand K, Reuter H: Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care. J Infect Dis. 2007, 196 (Suppl 3): S464-468. 10.1086/521114.CrossRefPubMed Bedelu M, Ford N, Hilderbrand K, Reuter H: Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care. J Infect Dis. 2007, 196 (Suppl 3): S464-468. 10.1086/521114.CrossRefPubMed
17.
go back to reference Weidle PJ, Wamai N, Solberg P, Liechty C, Sendagala S, Were W, Mermin J, Buchacz K, Behumbiize P, Ransom RL, Bunnell R: Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet. 2006, 368: 1587-1594. 10.1016/S0140-6736(06)69118-6.CrossRefPubMed Weidle PJ, Wamai N, Solberg P, Liechty C, Sendagala S, Were W, Mermin J, Buchacz K, Behumbiize P, Ransom RL, Bunnell R: Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet. 2006, 368: 1587-1594. 10.1016/S0140-6736(06)69118-6.CrossRefPubMed
18.
go back to reference Barth RE, Meer van der JT, Hoepelman AI, Schrooders PA, Vijver van de DA, Geelen SP, Tempelman HA: Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa. Eur J Clin Microbiol Infect Dis. 2008, 27: 977-984. 10.1007/s10096-008-0534-2.CrossRefPubMed Barth RE, Meer van der JT, Hoepelman AI, Schrooders PA, Vijver van de DA, Geelen SP, Tempelman HA: Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa. Eur J Clin Microbiol Infect Dis. 2008, 27: 977-984. 10.1007/s10096-008-0534-2.CrossRefPubMed
19.
go back to reference Carlucci JG, Kamanga A, Sheneberger R, Shepherd BE, Jenkins CA, Spurrier J, Vermund SH: Predictors of adherence to antiretroviral therapy in rural Zambia. J Acquir Immune Defic Syndr. 2008, 47: 615-622. 10.1097/QAI.0b013e318165dc25.CrossRefPubMedPubMedCentral Carlucci JG, Kamanga A, Sheneberger R, Shepherd BE, Jenkins CA, Spurrier J, Vermund SH: Predictors of adherence to antiretroviral therapy in rural Zambia. J Acquir Immune Defic Syndr. 2008, 47: 615-622. 10.1097/QAI.0b013e318165dc25.CrossRefPubMedPubMedCentral
20.
go back to reference Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, Karungi G, Szumilin E, Balandine S, Fedida G, et al: Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet. 2006, 367: 1335-1342. 10.1016/S0140-6736(06)68580-2.CrossRefPubMed Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, Karungi G, Szumilin E, Balandine S, Fedida G, et al: Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet. 2006, 367: 1335-1342. 10.1016/S0140-6736(06)68580-2.CrossRefPubMed
21.
go back to reference WHO: Antiretroviral therapy of HIV infection in infants and children: Towards universal access. Recommendations for a public health approach. 2006, Geneva, Switzerland: World Health Organization WHO: Antiretroviral therapy of HIV infection in infants and children: Towards universal access. Recommendations for a public health approach. 2006, Geneva, Switzerland: World Health Organization
23.
go back to reference Lusaka ZCSO: Zambia Demographic and Health Survey 2001-2002. 2003, Calverton, Maryland, USA: ORC and Macro International, Inc. Lusaka ZCSO: Zambia Demographic and Health Survey 2001-2002. 2003, Calverton, Maryland, USA: ORC and Macro International, Inc.
24.
go back to reference Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, Chi BH, Sinkala M, Kankasa C, Wilson CM, Wilfert CM, et al: Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. Jama. 2007, 298: 1888-1899. 10.1001/jama.298.16.1888.CrossRefPubMed Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, Chi BH, Sinkala M, Kankasa C, Wilson CM, Wilfert CM, et al: Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. Jama. 2007, 298: 1888-1899. 10.1001/jama.298.16.1888.CrossRefPubMed
25.
go back to reference Sutcliffe CG, Scott S, Mugala N, Ndhlovu Z, Monze M, Quinn TC, Cousens S, Griffin DE, Moss WJ: Survival from 9 months of age among HIV-infected and uninfected Zambian children prior to the availability of antiretroviral therapy. Clin Infect Dis. 2008, 47: 837-844. 10.1086/591203.CrossRefPubMedPubMedCentral Sutcliffe CG, Scott S, Mugala N, Ndhlovu Z, Monze M, Quinn TC, Cousens S, Griffin DE, Moss WJ: Survival from 9 months of age among HIV-infected and uninfected Zambian children prior to the availability of antiretroviral therapy. Clin Infect Dis. 2008, 47: 837-844. 10.1086/591203.CrossRefPubMedPubMedCentral
26.
go back to reference Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, Jean-Philippe P, McIntyre JA: Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008, 359: 2233-2244. 10.1056/NEJMoa0800971.CrossRefPubMedPubMedCentral Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, Jean-Philippe P, McIntyre JA: Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008, 359: 2233-2244. 10.1056/NEJMoa0800971.CrossRefPubMedPubMedCentral
27.
go back to reference Feucht UD, Kinzer M, Kruger M: Reasons for delay in initiation of antiretroviral therapy in a population of HIV-infected South African children. J Trop Pediatr. 2007, 53: 398-402. 10.1093/tropej/fmm060.CrossRefPubMed Feucht UD, Kinzer M, Kruger M: Reasons for delay in initiation of antiretroviral therapy in a population of HIV-infected South African children. J Trop Pediatr. 2007, 53: 398-402. 10.1093/tropej/fmm060.CrossRefPubMed
28.
go back to reference Marazzi MC, Germano P, Liotta G, Buonomo E, Guidotti G, Palombi L: Pediatric highly active antiretroviral therapy in Mozambique: an integrated model of care. Minerva Pediatr. 2006, 58: 483-490.PubMed Marazzi MC, Germano P, Liotta G, Buonomo E, Guidotti G, Palombi L: Pediatric highly active antiretroviral therapy in Mozambique: an integrated model of care. Minerva Pediatr. 2006, 58: 483-490.PubMed
29.
go back to reference Vreeman RC, Wiehe SE, Ayaya SO, Musick BS, Nyandiko WM: Association of antiretroviral and clinic adherence with orphan status among HIV-infected children in Western Kenya. J Acquir Immune Defic Syndr. 2008, 49: 163-170. 10.1097/QAI.0b013e318183a996.CrossRefPubMed Vreeman RC, Wiehe SE, Ayaya SO, Musick BS, Nyandiko WM: Association of antiretroviral and clinic adherence with orphan status among HIV-infected children in Western Kenya. J Acquir Immune Defic Syndr. 2008, 49: 163-170. 10.1097/QAI.0b013e318183a996.CrossRefPubMed
30.
go back to reference Polisset J, Ametonou F, Arrive E, Aho A, Perez F: Correlates of Adherence to Antiretroviral Therapy in HIV-Infected Children in Lome, Togo, West Africa. AIDS Behav. 2009, 13: 23-32. 10.1007/s10461-008-9437-6.CrossRefPubMed Polisset J, Ametonou F, Arrive E, Aho A, Perez F: Correlates of Adherence to Antiretroviral Therapy in HIV-Infected Children in Lome, Togo, West Africa. AIDS Behav. 2009, 13: 23-32. 10.1007/s10461-008-9437-6.CrossRefPubMed
31.
go back to reference Kabue MM, Kekitiinwa A, Maganda A, Risser JM, Chan W, Kline MW: Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda. AIDS Patient Care STDS. 2008, 22: 245-251. 10.1089/apc.2007.0049.CrossRefPubMed Kabue MM, Kekitiinwa A, Maganda A, Risser JM, Chan W, Kline MW: Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda. AIDS Patient Care STDS. 2008, 22: 245-251. 10.1089/apc.2007.0049.CrossRefPubMed
Metadata
Title
Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional analysis
Authors
Janneke H van Dijk
Catherine G Sutcliffe
Bornface Munsanje
Francis Hamangaba
Philip E Thuma
William J Moss
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2009
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-9-169

Other articles of this Issue 1/2009

BMC Infectious Diseases 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.